
Job Description:
The SMid-Cap Biotechnology Equity Research team currently covers ~35 listed companies spanning three main disease areas of oncology, central nervous system disorders, and rare diseases. The lead analyst is highly ranked in the Institutional Investor vote for the biotech category. In 2020, the team worked on 8 priced IPOs and is currently vetting a number of companies for potential IPOs and follow-on raises. This means that the candidate for this position should be intellectually curious and have a deep desire to learn. The ideal candidate possesses a life science background and experience with financial modeling, as well as passion to follow the stock market. He or she will work alongside the Senior Analyst and Associates in all aspects of the research process, from idea generation to modeling, including but not limited to the following:
Qualification:
Shift:
1st shift (United States of America)Hours Per Week:
40Learn more about this role
Located in midtown Manhattan, we’re right across from Bryant Park and a short walk to Times Square, Broadway theaters, Grand Central Station, excellent shops and world-class restaurants.